**Celltrion Secures Groundbreaking Autoimmune Disease Antibody Tech from Catholic University**

*Summary:* Celltrion has licensed a novel antibody platform from Catholic University that promises to reshape treatment strategies for rheumatoid arthritis, lupus, and other immune‑mediated disorders. For more details, see the source: Read the full announcement.

---

### Introduction
South Korean biopharma leader Celltrion announced on Monday that it has